BACKGROUND

A short notice opportunity exists to acquire the business assets of a long established and well regarded research, development and manufacturing company.

BUSINESS OVERVIEW

• Operating from leasehold premises in Southern England.
• In-house capability allowing full project delivery from conception, research, development, trials, regulatory approval, certification to box build manufacture.
• 19 highly skilled and knowledgeable staff including R&D, electrical, mechanical, software and product design engineers, supported by project managers, regulatory, clinical affairs and quality.
• Double Queen's Award winning and B Corp certified company.  ISO 9001:2015 and ISO 13485:2016, BSI Group, Cyber Essentials and VCA certified, together with Food and Drugs Administration (FDA) registered (US).
• The business works with Multinationals, SMEs, start-ups, inventors, doctors and higher education establishments.
• Assets to include tangible assets, Intellectual Property, goodwill, trading name, domain names and web content, right to pursue existing contracts and opportunities, client list.

FINANCIAL HIGHLIGHTS

	Year End 31/12/2022 £	Year End 31/12/2023 £	Year End 31/12/2024 £	Year End 31/12/2025 £
Turnover	1,022,790	1,408,120	743,356	424,848
Gross Profit	530,691	736,006	477,769	(70,339)
Other Operating Income	144,301	257,945	412,498	1,336,131
Net Profit/(Loss)	(359,678)	(321,914)	(454,784)	(199,154)

IMPORTANT

This briefing sheet contains information supplied by company personnel. LSH provides no warranties or indemnities in respect of such information. All interested parties must rely on their own investigations when reviewing this opportunity.